Cannabis Insight | Legalization 2022 & HEXO Meeting (TLRY)

06/13/22 07:52AM EDT

Cannabis Insight | Legalization 2022 & HEXO Meeting (TLRY) - 2022 06 12 12 24 05

LEGALIZATION in 2022

Halfway through 2022, only Rhode Island has legalized recreational marijuana sales through its Legislature. Efforts to push through adult-use legislation in Ohio, Hawaii, New Hampshire, and Delaware ran off the rails. Similarly, on the medical front, Mississippi is the only state to pass legislation establishing a program so far in 2022. Kentucky, Tennessee, Kansas, and South Carolina legislative efforts failed to pass. Those setbacks hardly mean that 2022 will be a year that bucks the recent rapid growth trend in state-legal markets. While most state legislatures have already adjourned for the year, legalization advocates in seven states are pushing forward with potential recreational or medical legalization referendums in November. 

Legislation still alive in North Carolina and Pennsylvania

Ballot referendums are still alive in Maryland, South Dakota, Arkansas, Missouri, Oklahoma, North Dakota, and Nebraska. 

HEXO has very little chance of surviving the shakeout of Canadian LP's

HEXO extraordinary shareholders meeting June 14, 2022

For some unexplained reason, TLRY bailed out HEXO for the time being, despite its financial trouble and poor management. Indeed, along with CGC, ACB, and TLRY, the stock has slumped over 90% from its post-legalization peak. Investors are begging for an update on Tuesday's Hexo performance at the shareholders' earnings. There is little hope of reviving sentiment in a space that has become overwhelmingly negative. The meeting will be the first under newly minted CEO and CFO Charlie Bowman and Julian Ivancsits.

Cannabis Insight | Legalization 2022 & HEXO Meeting (TLRY) - 2022 06 13 7 14 30

© 2024 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.